BioCentury
ARTICLE | Financial News

Forest proposes $1.8 billion note deal

January 28, 2014 12:51 AM UTC

Forest Laboratories Inc. (NYSE:FRX) plans to raise $1.8 billion through the sale of senior unsecured notes due 2019 and 2021. The company said it plans to use the proceeds for its acquisition of gastrointestinal company Aptalis Holdings Inc. (Bridgewater, N.J.). Earlier this month, Forest said it would acquire Aptalis for $2.9 billion in cash (see BioCentury Extra, Jan. 8). ...